Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leyvraz

Showing results (401-410 of 405) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 405 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma studyL Khoja, E G Atenafu, S Suciu, et al.
Blood|January 9, 2007
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeHervé Avet-Loiseau, Michel Attal, Philippe Moreau, et al.
Oncoimmunology|February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patientsSylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers InitiativeJan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Pageof 41

Showing results (401-410 of 405) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 405 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma studyL Khoja, E G Atenafu, S Suciu, et al.
Blood|January 9, 2007
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeHervé Avet-Loiseau, Michel Attal, Philippe Moreau, et al.
Oncoimmunology|February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patientsSylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers InitiativeJan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Pageof 41